Kepivance Drug Interactions
Currently displaying a list of 129 drugs known to interact with Kepivance (palifermin).
- 1 major drug interaction
- 128 moderate drug interactions
Medications known to interact with Kepivance
Note: Showing generic names only.
A
B
- bendamustine
- bevacizumab
- bexarotene
- bleomycin
- blinatumomab
- bortezomib
- bosutinib
- brentuximab
- busulfan
C
- cabazitaxel
- cabozantinib
- capecitabine
- carboplatin
- carfilzomib
- carmustine
- chlorambucil
- cisplatin
- cladribine
- clofarabine
- cobimetinib
- copanlisib
- crizotinib
- cyclophosphamide
- cytarabine
D
- dacarbazine
- dactinomycin
- dasatinib
- daunorubicin
- daunorubicin liposomal
- decitabine
- docetaxel
- doxorubicin
- doxorubicin liposomal
- duvelisib
E
F
G
H
I
- ibritumomab
- ibrutinib
- idarubicin
- ifosfamide
- imatinib
- imetelstat
- inotuzumab ozogamicin
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon gamma-1b
- iobenguane I 131
- irinotecan
- irinotecan liposomal
- ixabepilone
L
M
- mechlorethamine
- melphalan
- melphalan flufenamide
- mercaptopurine
- methotrexate
- mitomycin
- mitoxantrone
- mosunetuzumab
N
O
P
- paclitaxel
- paclitaxel protein-bound
- pazopanib
- peginterferon alfa-2a
- peginterferon alfa-2b
- pemetrexed
- pentostatin
- plicamycin
- pomalidomide
- ponatinib
- pralatrexate
- procarbazine
Q
R
S
T
- talazoparib
- teclistamab
- temozolomide
- teniposide
- thalidomide
- thioguanine
- thiotepa
- topotecan
- trabectedin
- trastuzumab
- treosulfan
- trimetrexate
U
V
Report options
QR code containing a link to this page
More about Kepivance (palifermin)
- Kepivance consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.